Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages - PubMed (original) (raw)

Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages

Dan Feng et al. Inflamm Res. 2010 Feb.

Abstract

Background: Lycopene has antioxidant, anticancer, and anti-inflammatory effects with molecular mechanisms not fully identified.

Aim and methods: We investigated the effects of lycopene on the inflammatory responses to lipopolysaccharide (LPS) in RAW264.7 cells and the signal transduction pathways involved.

Results: Lycopene inhibited LPS-induced production of nitric oxide (NO) and interleukin-6 (IL-6) with decreased mRNAs of inducible nitric oxide synthase and IL-6 but had no effect on TNF-alpha. Further study showed that lycopene also inhibited LPS-induced IkappaB phosphorylation, IkappaB degradation, and NF-kappaB translocation. Moreover, lycopene blocked the phosphorylation of ERK1/2 and p38 MAP kinase but not c-Jun NH(2)-terminal kinase. To confirm the causal link between MAP kinase inhibition and its anti-inflammatory effects, we treated the cells with SB 203580 and U0126. These inhibitors significantly inhibited LPS-induced NO and IL-6 formation.

Conclusion: Lycopene inhibits the inflammatory response of RAW 264.7 cells to LPS through inhibiting ERK/p38 MAP kinase and the NF-kappaB pathway.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunol Invest. 2008;37(3):183-90 - PubMed
    1. Essays Biochem. 2008;45:95-107 - PubMed
    1. Anal Biochem. 1982 Oct;126(1):131-8 - PubMed
    1. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 - PubMed
    1. Oncogene. 2007 May 14;26(22):3240-53 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources